Should Teenagers Take Ozempic? - What the Science Actually Says

from Should Teenagers Take Ozempic? · host Inception Point AI

Miss Olivia Harper examines the science behind FDA-approved weight loss drugs like Wegovy for adolescents aged 12-17 with obesity. We cover clinical trial data showing 5-17% BMI reductions, concerns about long-term effects on developing bodies, the AAP's landmark 2023 guidelines, surging prescription rates including off-label Ozempic use, and why systemic factors matter as much as medication. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Episode metadata supplied by the publisher feed · Published Apr 7, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Should Teenagers Take Ozempic? - What the Science Actually Says

0:00 25:49

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Should Teenagers Take Ozempic??

This episode is 25 minutes long.

When was this Should Teenagers Take Ozempic? episode published?

This episode was published on April 7, 2026.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Should Teenagers Take Ozempic? episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!